Diana Brainard - 31 Dec 2024 Form 5 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Director
Signature
Mark A. Wilson, Attorney-in-Fact
Issuer symbol
NKTR
Transactions as of
31 Dec 2024
Transactions value $
$0
Form type
5
Filing time
17 Jan 2025, 20:32:48 UTC
Previous filing
20 Nov 2024
Next filing
01 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTR Stock Option Award $0 +120,000 $0.000000 120,000 18 Sep 2024 Common Stock 120,000 $1.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in equal monthly installments over the one-year period beginning on September 18, 2024.